OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond probiotic legend: ESSAP gut microbiota health score to delineate SARS-COV-2 infection severity
Mona Hegazy, Omar Ashoush, Mohamed Tharwat Hegazy, et al.
British Journal Of Nutrition (2021) Vol. 127, Iss. 8, pp. 1180-1189
Open Access | Times Cited: 23

Showing 23 citing articles:

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 182

Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review
Douglas Xavier-Santos, Marina Padilha, Giovanna Alexandre Fabiano, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 174-192
Open Access | Times Cited: 97

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 67

Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review
Yeganeh Farsi, Azin Tahvildari, Mahta Arbabi, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 60

Role of the Microbiome in the Pathogenesis of COVID-19
Rituparna De, Shanta Dutta
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30

A critical review of novel antibiotic resistance prevention approaches with a focus on postbiotics
Mahdi Asghari Ozma, Seyyed Reza Moaddab, Hedayat Hosseini, et al.
Critical Reviews in Food Science and Nutrition (2023), pp. 1-19
Closed Access | Times Cited: 18

Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential
Gerasimos Eleftheriotis, Efthymios P. Tsounis, Ιωάννα Αγγελετοπούλου, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17

Gut Microbiome Disruption Following SARS-CoV-2: A Review
Elda Righi, Ilaria Dalla Vecchia, Nina Auerbach, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 131-131
Open Access | Times Cited: 6

The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review
Mahmoud Yousef, Mlaak Rob, Sanish Varghese, et al.
Life Sciences (2024) Vol. 342, pp. 122535-122535
Open Access | Times Cited: 6

Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda
Carolina Agudelo, David Patrick Kateete, Emmanuel Nasinghe, et al.
Gut Pathogens (2025) Vol. 17, Iss. 1
Open Access

Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support
Marta Giovanetti, Gianfranco Pannella, Annamaria Altomare, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 370-370
Open Access | Times Cited: 4

Patient Nutrition and Probiotic Therapy in COVID-19: What Do We Know in 2021?
Viktoria Hawryłkowicz, Danuta Lietz‐Kijak, Karolina Kaźmierczak-Siedlecka, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3385-3385
Open Access | Times Cited: 23

Retracted: Gut microbiota and COVID‐19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Health Science Reports (2023) Vol. 6, Iss. 2
Open Access | Times Cited: 9

Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, et al.
Exploration of Targeted Anti-tumor Therapy (2022), pp. 817-827
Open Access | Times Cited: 8

Non-alcoholic fatty liver disease related knowledge among a sample of Egyptians: an exploratory cross-sectional study
Mona Hegazy, Arwa Elshafei, Marwa Rashad Salem, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 1

The association between macronutrient intakes and coronavirus disease 2019 (COVID-19) in an Iranian population: applying a dynamical system model
Somayeh Ghiasi Hafezi, Najmeh Seifi, Hossein Bahari, et al.
Journal of Health Population and Nutrition (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 3

The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes
Jiezhong Chen, Luis Vitetta
Frontiers in Bioscience-Scholar (2022) Vol. 14, Iss. 3, pp. 23-23
Open Access | Times Cited: 5

Dietary recommendations for people with diabetes in special situations: a position statement report by Arabic Association for the Study of Diabetes and metabolism (AASD)
Amin Roshdy Soliman, Mona Hegazy, Rabab Mahmoud Ahmed, et al.
Journal of Health Population and Nutrition (2024) Vol. 43, Iss. 1
Open Access

Probiotics in prevention and treatment of COVID-19: a systematic review of current evidence
SeyedAhmad SeyedAlinaghi, Ramin Shahidi, Arian Afzalian, et al.
Russian Journal of Infection and Immunity (2023) Vol. 13, Iss. 4, pp. 709-722
Open Access | Times Cited: 1

Gut microbiota and COVID-19: A systematic review
SeyedAhmad SeyedAlinaghi, Arian Afzalian, Zahra Pashaei, et al.
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top